Studies from Unit of Research Describe New Findings in COVID-19 (Immune Response To Sars-cov-2 Third Vaccine In Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-dose Regimen With Inactivated or Vector-based Vaccines).

Předmět:	COVID-19 vaccines RHEUMATOID arthritis IMMUNE response SEROCONVERSION COVID-19
Zdroj:	NewsRx COVID-19 Weekly; 2/17/2023, p77-77, 1p
Abstrakt:	For more information on this research see: Immune Response To Sars-cov-2Third Vaccine In Patients With Rheumatoid Arthritis Who Had NoSeroconversion After Primary 2-dose Regimen With Inactivated orVector-based Vaccines. Patients with RAwith no seroconversion after 2 doses of SARS-CoV-2 vaccine and whoreceived a third dose of either an mRNA or vector-based vaccine wereincluded.". [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu